As a result of Elmiron, did you suffered from blurred vision or macular degeneration after taking the prescription drug? Did you receive a mail about a class action on the settlement to resolve claims about baby formula given while in the NICU? This review will help you partake in the class action settlement after confirming the authenticity of the mail.
What Is Elmiron vision loss Class Action Settlement?
Elmiron is an oral medication prescribed to treat interstitial cystitis a painful bladder disorder also called “bladder pain syndrome.” It’s a semi-synthetic drug derived from xylan, a substance found in the bark of the beech tree.
Among the side effects from Elmiron are vision problems including a severe condition called pigmentary maculopathy also called macular degeneration, which is a condition that causes loss of central vision first, and can eventually lead to blindness.
Reports of a link between retina issues and Elmiron surfaced in 2018.
What Is This Class Action All About?
In May 2020, a New York woman filed a lawsuit against Johnson & Johnson subsidiary Janssen Pharmaceuticals alleging she suffers from maculopathy, blurry vision, and cloudy vision as a result of taking Elmiron from about 2003 to 2020.
Researchers are uncertain why vision side effects may develop from Elmiron. One theory is that the drug may generate a toxic metabolite that affects the eyes, Forbes reported. The news organization cited a study from Kaiser Permanente that found about 25% of their patients with long-term exposure to the drug showed clear evidence of retinal damage.
Plaintiff Becky W. claims she did not receive a warning regarding any serious risks of retinal damage, macular degeneration, or vision loss posed by her ingestion of Elmiron. Court documents indicate Janssen failed to investigate the risks to a patient’s vision even though a physician’s usage study conducted in the late 1980s and early 1990s allegedly noted adverse side effects such as optic neuritis and retinal hemorrhage (bleeding).
Who Is Eligible?
The settlement benefits all class members who suffered vision loss after taking the drug Elmiron, you may qualify to participate in an Elmiron lawsuit investigation.
Qualifying diagnoses after one (1) year of Elmiron use include:
- Pigmentation Macular Degeneration
- Pigmentation Maculopathy
- Pigmentation Maculitis
- Retinal Maculopathy
- Dry Macular Degeneration
- Retinal Pigment Epithelium
How To Be Part of This Settlement
For a class member to partake in this settlement, they must submit their Valid claim on the settlement website.
What Is The Pay For This Settlement?
The pay for this settlement varies and the proof of purchase is not necessary.
Conclusion
As you submit your claim to the settlement website, just like Camp Lejeune class action settlement we have reviewed , you’re doing so under penalty of perjury. You are also harming other eligible Class Members by submitting a fraudulent claim.
